AXIL Axil Brands, Inc.
Perfumes, Cosmetics & Other Toilet Preparations · NYSE · SEC CIK 1718500 · Fiscal year ends 05/31
Financial factors as of 2026-08-31 (2027Q1), TTM = sum of the last four quarters
Growth
TTM revenue YoY10.3%
TTM net income YoY114.4%
TTM EPS YoY112.5%
Revenue 3-yr CAGR5.8%
Net income 3-yr CAGR15.6%
Margins
Gross margin72.4%
Operating margin10.0%
Net margin9.3%
FCF margin14.5%
EBITDA margin10.6%
Returns
ROE23.3%
ROA16.4%
ROIC (approx.)43.2%
Asset turnover1.77x
Leverage & solvency
Liabilities / assets25.3%
Debt / equity0.00x
Current ratio3.31x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.61x
Accruals ratio-10.1%
Payout ratio—
Capex / revenue0.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-05-31 | FY20252025-05-31 |
|---|---|---|
| Income statement | ||
| Revenue | $30.85M | $26.26M |
| Cost of revenue | $9.42M | $7.58M |
| Gross profit | $21.38M | $18.64M |
| SG&A expense | $4.12M | $4.06M |
| Operating income | $2.98M | $1.16M |
| Interest expense | $2,587 | $3,898 |
| Pretax income | $3.14M | $1.31M |
| Income tax | $440,310 | $453,828 |
| Net income | $2.70M | $854,988 |
| EBITDA | $3.22M | $1.31M |
| EPS (basic) | 0.40 | 0.13 |
| EPS (diluted) | 0.33 | 0.10 |
| Weighted avg. shares (diluted) | 8.26M | 8.22M |
| Balance sheet | ||
| Cash & equivalents | $4.46M | $4.77M |
| Inventory | $4.42M | $2.53M |
| Current assets | $14.34M | $9.26M |
| PP&E, net | $389,733 | $412,261 |
| Goodwill | $2.15M | $2.15M |
| Intangibles | $389,747 | $403,591 |
| Total assets | $17.96M | $12.87M |
| Current liabilities | $4.50M | $2.46M |
| Long-term debt | — | $140,229 |
| Total debt | — | $140,229 |
| Total liabilities | $4.81M | $3.21M |
| Shareholders' equity | $13.14M | $9.66M |
| Net debt | — | -$4.63M |
| Shares outstanding | 6.82M | 6.66M |
| Cash flow statement | ||
| Operating cash flow | -$9,635 | $1.93M |
| Capital expenditure | $79,385 | $213,483 |
| Free cash flow | -$89,020 | $1.72M |
| Investing cash flow | -$210,349 | -$394,298 |
| Financing cash flow | -$87,830 | -$18,385 |
| Depreciation & amortization | $246,723 | $148,498 |
| Stock-based compensation | $785,160 | $1.11M |
Free plan shows the latest 2 periods; Pro shows all 10 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.